Ra Capital Management Funds Increase Stake in Artiva Biotherapeutics Amid Clinical Momentum
RA Capital Management funds have executed recent purchases of Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) common stock, adding to their existing institutional positions. This buying activity occurs against a backdrop of significant clinical developments for the biotechnology company, including a Regenerative Medicine Advanced Therapy designation fr…